// App-Quantinova.ai

384 2014 ATVB : The Prothrombotic Profile of BCR-ABL Inhibitors Ponatinib, Nilotinib and Imatinib

Researchers

Presenter

  • Rachel A Rigg

Principal Investigators

  • Joseph E Aslan

  • Laura D Healy

  • Andras Gruber

  • Owen J McCarty

Medical Centers

  • Oregon Health and Science University, Portland, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Fibrinogen (IV)

  • Nilotinib

  • Ponatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim